Frontiers in medicine · 2025
Global burden of polycystic ovary syndrome, uterine cancer and diabetes mellitus type 2 among women of childbearing age: trends in incidence, prevalence, mortality, and disability-adjusted life-years from 1990 to 2021.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xie Ming Zhu, Qin MaoHua, Yang ZhaoJun, Huang RongXia, Qin Rong
Аннотация
BACKGROUND: Polycystic ovary syndrome (PCOS), uterine cancer, and type 2 diabetes mellitus (T2DM) are major health concerns for women of childbearing age (WCBA), with complex pathogenesis and significant global burden. Understanding their epidemiological trends and risk factors is critical for public health planning.
METHODS: Data from the Global Burden of Disease (GBD) 2021 database were analyzed to assess the burden of PCOS, uterine cancer, and T2DM across 204 countries and territories from 1990 to 2021. Age-standardized rates of prevalence, mortality, disability-adjusted life-years (DALYs), and estimated annual percentage changes (EAPCs) were evaluated. Risk factor contributions, including high body mass index (BMI) and metabolic risks, were also examined.
RESULTS: In 2021, T2DM had the highest age-standardized incidence rate (267.85 per 100,000), followed by PCOS (64.44) and uterine cancer (2.87). From 1990 to 2021, T2DM incidence rose most significantly, while PCOS and uterine cancer also showed increasing trends. High BMI contributed to 30.76% of uterine cancer deaths and 62.87% of T2DM deaths, whereas metabolic risks accounted for 100% of T2DM deaths.
CONCLUSION: The rising global burden of PCOS, uterine cancer, and T2DM underscores a pressing public health challenge. Prioritizing healthy lifestyles in high-burden regions and fostering international collaboration are essential to mitigate these trends.
METHODS: Data from the Global Burden of Disease (GBD) 2021 database were analyzed to assess the burden of PCOS, uterine cancer, and T2DM across 204 countries and territories from 1990 to 2021. Age-standardized rates of prevalence, mortality, disability-adjusted life-years (DALYs), and estimated annual percentage changes (EAPCs) were evaluated. Risk factor contributions, including high body mass index (BMI) and metabolic risks, were also examined.
RESULTS: In 2021, T2DM had the highest age-standardized incidence rate (267.85 per 100,000), followed by PCOS (64.44) and uterine cancer (2.87). From 1990 to 2021, T2DM incidence rose most significantly, while PCOS and uterine cancer also showed increasing trends. High BMI contributed to 30.76% of uterine cancer deaths and 62.87% of T2DM deaths, whereas metabolic risks accounted for 100% of T2DM deaths.
CONCLUSION: The rising global burden of PCOS, uterine cancer, and T2DM underscores a pressing public health challenge. Prioritizing healthy lifestyles in high-burden regions and fostering international collaboration are essential to mitigate these trends.